IMV News and Press, IMV Inc. From 08/05/20

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...

Aerpio Pharmaceuticals (NASDAQ: ARPO ) +61%  on announcing a second clinical trial with funding from MTEC. More news on: Aerpio Pharmaceuticals, Inc., Whiting Petroleum Corporation, Hepion Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Nova Scotia-based IMV (NASDAQ: IMV ) announces that Canadian government agencies have committed funding of C$4.75M to support manufacturing scale-up and a Phase 1 clinical trial evaluating COVID-19 vaccine candidate DPX-COVID-19. It also received C$600K from the National Research Council...

Contribution totalling Cdn$4.75 Million will support Phase 1 clinical development and manufacturing of DPX-COVID-19 IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, ...

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases including COVID-19, announced today that it will hold a co...

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that company management will present at BTIG’s Virtual Biotechnology Conference on Monday August 10, 2020 at 11 a.m. EDT. A live webcast of this...

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced the appointment of Michael P. Bailey to its Board of Directors. Mr. Bailey currently serves as President an...

Moderna (NASDAQ: MRNA) announced the publication of positive results from a phase 1 study of its COVID-19 vaccine candidate mRNA-1273 late Tuesday. But those results led to the stocks of several other drugmakers working on experimental vaccines against the novel coronavirus that causes COV...

Perceptron (NASDAQ: PRCP ) -15% . More news on: Perceptron, Inc., Zynex, Inc., Rigel Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Gainers:  INmune Bio (NASDAQ: INMB ) +114% . More news on: INmune Bio, Inc., Perceptron, Inc., Rigel Pharmaceuticals, Inc., Stocks on the move, , Read more ...